METHODS:
We used data on the population and number of deaths by cause, age and sex in 1965, 1975, 1985 and 1995 
METHODS
To study the contribution of change in mortality from malignant neoplasms to the life expectancy at birth by age, we classified the data into 5 groups according to subject age as follows: 0-14, 15-44, 45-64, 65-74, and 75 years or over. The basic data used in the present study to analyze the contributions in these 5 groups were population size and the number of deaths by cause, age (5-year groups), and sex in 1965, 1975, 1985 , and 1995 from the vital statistics of Japan.12-14 Life expectancies were estimated from the complete life tables in 1965, 1975, 1985 , and 1995.1 We analyzed the changes in cause of death for each of the following 10-year periods: 1965-1975, 1975-1985, and 1985-1995 . All the diseases examined were cancers; namely, cancers of the stomach; small intestine including the duodenum and colon (intestine); recturn, rectosigmoid junction and anus (rectum); liver and intrahepatic bile ducts (liver); gallbladder and extrahepatic bile ducts (gallbladder); trachea, bronchus and lung (lung); breast; uterus; prostate and other sites. The causes of death were classified according to the International Classification of Diseases and Causes of Death (ICD) as shown in Table 1 .
When a life table was applied at the two time points ti and t2, the difference in life expectancy at birth e02-e01 depended on the changes in mortality for each age group at the two time points. Thus, using the method of Pollard,15-17 we were able to evaluate the differences in life expectancy at birth at these two times produced by changes in mortality from different causes of death. The method of Pollard is based on the concept that the difference in life expectancy at birth between two time points can be calculated by summing the difference of appropriately weighted mortality by cause and age at the two points of time.
Thus, we weighted changes in life expectancy against changes in mortality by malignant neoplasms, and calculated this as contributing years.
The following approximate formula can be used to analyze change in life expectancy at birth according to mortality trends by age and cause:
where the suffixes 1 and 2 on the life table functions and mortality rate refer to times 1 and 2; tpx1, tpx2 is the probability of survival t years from x at times 1 and 2, respectively; ex1, ex2 is the expectation of life at age x; and nmx(i)1, nmx(i)2 is the central mortality rate for cause i in an age interval (x, x+n-1) at times 1 and 2, respectively. nDx is the number of deaths from all causes in an age interval (x, x+n-1), and nDx(i) is the number of deaths by cause i in an age interval (x, x+n-1). Finally, wt is the weight function. [1, 5) , [5, 10) , [10, 15) ...(where "[a,b)" represents "a<=x<b"), this integral was approximated for each short interval. We could calculate the contributing years by cause, using the central mortality rate weighted by the proportion of the number of deaths from malignant neoplasms against the number of deaths from all causes.
A positive contribution indicates that a mortality reduction in the relevant age group contributes to an increase in life expectancy at birth, whereas a negative contribution indicates that a mortality increase contributes to a reduction in life expectancy at birth. For this paper, we estimated the contributions of malignant neoplasms to changes in life expectancy by age group and cause of death. Table 2 shows the contributing years for age and sites of malignant neoplasms from 1965 to 1995 for males and females, respectively. The contributing years of all causes to the changes of life expectancy at birth were The contributions of death from all cancers to the change in life expectancy at birth between 1965 and 1975 were 0.070 years for males and 0.202 years for females. In terms of the sites of malignant neoplasms, the contributing years for stomach cancer was the largest for males (0.221 years) and females (0.157 years). The major causes showing a positive contribution were uterine cancer (0.105 years) and liver cancer (0.033 years) for females. On the other hand, male lung cancer (-0.080 years) and female gallbladder cancer (-0.031 years) had the largest negative contribution. Other large negative contributions were due to intestinal cancer (-0.023 years) for males, and cancer of the breast (-0.025 years) and lung (-0.022 years) for females.
RESULTS
By age group, a negative contribution was seen among the middle-aged and elderly in both sexes. The majority of the positive contribution was accounted for by stomach cancer in age 45-64 (males: 0.140 years, females: 0.086 years). Death from male lung cancer in age 65-74 and female breast cancer in age 45-64 was the major factor shortening life expectancy, -0.038 years and -0.016 years, respectively.
The contribution of total cancer to the changes of life expectancy at birth between 1975 and 1985 was -0.083 years among males and 0.211 years among females. Cancer in males showed a negative contribution during this decade. Stomach cancer in both sexes showed the largest weight in improvements in life expectancy (0.287 years and 0.236 years, males and females, respectively), as is the case with the years 1965-75. Female uterine cancer (0.099 years) and rectal cancer (0.017 years) were the major causes contributing positively. A negative contribution with the largest weight was seen in lung cancer (-0.126 years), liver cancer (-0.121 years) and intestinal cancer (-0.042 years) for males and cancer of lung (-0.043 years), gallbladder (-0.040 years) and intestine (-0.038 years) for females.
By age, stomach cancer at ages 45-64 in both sexes accounted for the majority of the positive contribution to the changes of life expectancy at birth (males: 0.128 years, females: 0.098 years). Conversely, the major factors for reduced life expectancy at birth were liver cancer in the 45-64 age group for males (-0.093 years) and lung cancer in the 75 years and older age group for females (-0.025 years).
The number of years contributed by age group during the years from 1985 to 1995 showed a decrease for males (-0.037 years) and increase for females (0.155 years). The major cause of death showing a positive contribution was stomach cancer in both sexes (males: 0.215 years, females: 0.204 years). Other causes contributing positively were uterine cancer (0.036 years) and cancer of the gallbladder (0.019 years) in females. The leading causes showing reduction of life expectancy at birth were liver cancer (-0.069 years) in men and breast cancer (-0.050 years) in women. In addition, lung cancer (-0.064 years) and intestinal cancer (-0.049 years) for males and cancer of the intestine (-0.031 years) and liver (-0.030 years) for females contributed negatively to the changes of life expectancy at birth.
By age, reduction of mortality from stomach cancer among the 45-64 age group made the most positive contribution in both sexes (males: 0.099 years, females: 0.068 years). Conversely, the major causes and age groups showing a negative contribution were liver cancer in the 65-74 age group for males (-0.055 years) and breast cancer in the 45-64 age group for females (-0.033 years).
DISCUSSION
In this study, we evaluated the contribution of the change in mortality from malignant neoplasms to the life expectancy at birth during the years 1965-1995 in Japan. The decreased mortality from stomach cancer for both sexes had a great impact on the improvement in life expectancy. On the other hand, factors showing a negative contribution by increasing mortality were cancer of the intestine, liver and lung for males, and cancer of the intestine, gallbladder, lung and breast for females. Negative contributions were seen for cancers of many sites in both sexes. In recent years, the contributing years of all cancers has been negative because of an increase in mortality from malignant neoplasms. As a result of an analysis similar to ours, Ngongo et al. reported the negative contribution of lung cancer for both sexes and breast cancer for Table 2 . Contributions of changes in mortality from malignant neoplasms to life expectancy at birth between 1965 and 1995 Values and percentages in this column may not add up exactly to the total number and 100% because of rounding, respectively. In this study. we excluded the sites of cancer for which the contribution from changes in malignant neoplasm mortality against changes in life expectancy from all causes of death was small (under about 1%) during each of the 10 years.
(1) The proportion of the contribution from changes in malignant neoplasm mortality against changes in life expectancy from all causes of death.
(2) Intestine: Small intestine, including duodenum and colon (3) Rectum Rectum. rectosigmoid junction and anus (4) Liver. Liv and intrahepatic bile ducts (5) Gallbladder Gallbladder and extrahepatic bile duets (6) Lung Trachea, bronchus and lung females to the changes of life expectancy at birth in Italy during 1980-1992.10 Their results showed the same trends as in our study.
Stomach cancer contributed positively to the changes of life expectancy at birth in both sexes among all age groups. As the contributing years at age 45-64 was the highest of all age groups, the mortality from stomach cancer in middle age was decreased.
Many studies have reported a continuing decline in mortality from stomach cancer in various countries including Japan.18-21
However, deaths from stomach cancer account for the majority of cancer deaths recently. The number of deaths from stomach cancer in young and middle aged groups has decreased, but the number of deaths in elderly groups remains high. In fact, Levi reported that Japanese mortality from stomach cancer at age 65-84 years was the highest in the industrialized countries in the early 1990s.22
The contribution of cancer of the intestine among Japanese has been negative for both sexes. The contributing years at age 45 years or over were negative. Intestine cancer at age 45-64 showed the most negative contributions during the years 1965-1985 in both sexes. However, the age groups showing the most negative The contribution of cancer of the breast at age 15 years or over has been negative during the years 1965-1995. The negative contributing years were the largest in the 45-64 age group. Breast cancer mortality at age 20-69 years declined by 22% in the UK and 19% in the USA between 1981 and 1997. 33 In the European Union as a whole, the overall age-adjusted mortality rate from breast cancer showed a downward trend in recent years.34,35 An increase of mortality from breast cancer among Japanese, however, was a factor reducing life expectancy at birth.
Using the method of Pollard, we could evaluate the extent to which changes of mortality in two different time periods influenced the changes in life expectancy at birth by cause and age group. Moreover, this method provides a more accurate estimate of the influence on contributing years by weighting deaths occurring at younger ages more heavily than those occurring in older age groups. [15] [16] [17] In this study, we found that the positive or negative contribution of malignant neoplasms to the changes of life expectancy at birth was much larger in elderly people than in young people. This is the reason mortality from malignant neoplasms among elderly groups produced remarkable positive or negative changes of life expectancy at birth, while cancer mortality among younger age groups has little impact on changes of life expectancy.
Improvement of measures to overcome cancer such as stomach cancer screening and treatment lead to an increased life expectancy at birth in young and middle aged people under 64 years old. However, the contribution of cancer has been negative for males 65 years or over and female 75 years or over, and the proportion of aged people dying from cancer has increased. One method to estimate the contributions by cause of death is known as the potential gains in life expectancy by complete elimination of a specific cause of death.36,37 The potential gains are regarded as the expectation of life lost by death from cancer. This means that the impact of death from cancer on life expectancy becomes larger as potential gains increase. The potential gain in life expectancy at birth (life expectancy at age 0) by elimination of deaths from cancer ranked second behind that from elimination of cerebrovascular disease in 1965 (males: 2.02 years, females: 1.98 years). Since then, it has continued to increase remarkably, and ranked first in 1995 (males: 3.84 years, females: 2.76 years). The potential gains in life expectancy at age 65 by elimination of deaths from cancer were estimated at 1.07 years for males and 2.69 years for females in 1965 against 2.69 years and 1.72 years for males and females in 1995, respectively.1 Compared with the potential gains in life expectancy at birth by elimination of deaths from cancer, the potential gains in life expectancy at age 65 were large. It is suggested that a high proportion of aged people died from cancer.
In conclusion, female cancer influenced the improvement in life expectancy at birth. Cancer in males, however, contributed little to improvement of life expectancy at birth except for a little prolongation of life expectancy at birth during the years [1965] [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] [1974] [1975] . Quantitatively evaluating the burden of diseases in a popu-lation and computing the potential impact on deaths from various diseases such as cancer is important in the development of a public health policy. Therefore, the contributing years to life expectancy at birth can be a useful indicator in evaluating the impact of death from various diseases. In the future, it will be necessary to analyze the contribution to the changes of life expectancy at birth by various causes of death.
